SCHEMBL24042564

SCHEMBL24042564

O=C(NCc1cnco1)Nc1ccc2nc(-c3ccccc3)nn2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 19/20 1.00
▸ PDE10A Q9Y233 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24042545 0.82 NAMPT (1.00) NAMPT
SCHEMBL24042598 0.79 NAMPT (1.00) NAMPT
SCHEMBL23432009 0.78 NAMPT (0.77) NAMPT
SCHEMBL23320451 0.73 NAMPT (0.69) NAMPT
SCHEMBL20389421 0.73 NAMPT (0.69) NAMPT
SCHEMBL20379901 0.72 NAMPT (1.00) NAMPT
SCHEMBL24042535 0.72 NAMPT (0.70) NAMPT
SCHEMBL20380306 0.71 NAMPT (1.00) NAMPT
SCHEMBL20379639 0.71 NAMPT (1.00) NAMPT
SCHEMBL20389172 0.71 NAMPT (0.66) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112654608-B Fused ring compound having urea structure 桑福德伯纳姆普利斯医学发现研究所 2024-05-07 — — CN disclosed
US-20210361636-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE DAIICHI SANKYO COMPANY LIMITED (JP) 2021-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210361636-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE NAMPT, NME4, ABAT NAMPT 1/4885PDE10A 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback